Johnson & Johnson (JNJ.US) Experimental Shockwave Javelin Catheter Technology Achieves 94% Success Rate, Potentially Expanding the Complex Coronary Artery Surgery Market

date
02/11/2026
Zhitong Finance APP has learned that Johnson & Johnson (JNJ.US) announced positive 30-day results on Sunday from the clinical trial of its experimental Shockwave Javelin catheter. The catheter is used to treat severely narrowed coronary arteries that are difficult to reach with conventional devices.
Latest
See all latestmore